© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Hua Medicine has filed for an IPO in Hong Kong under sponsors CLSA and Goldman Sachs, as the promised pipeline of biotechnology issuers begins to materialise following the city’s new listing rules.
  • The cloud which has lingered over the European IPO market since Easter, has abated slightly this week as a number of deals progressed quickly during bookbuilding. Two in particular have outperformed the rest of the market.
  • Two Chinese online platform businesses will start pre-deal investor education for their Hong Kong IPOs on Thursday, according to bankers.
  • China has had a busy fortnight in capital reform, with its long-awaited entry into MSCI, and progress in plans for Chinese firms to list in London and Frankfurt. Yet it is becoming clear that regulators should focus on Hong Kong links, rather than opening up new markets.
  • The IPO of Adyen, the Dutch payments company, which is one of the most anticipated listings in Europe this year, has got off to a good start, with the book covered throughout the range just over an hour after being opened.
  • China-based VCredit Holdings, which provides online consumer finance, launched bookbuilding for its IPO on Tuesday, with proceeds of up to HK$1.58bn ($201m) in reach.